Long-term dosage effects of psychodynamic and schema therapy in depressed patients with personality disorders: 18 and 24 months follow-up of a randomized controlled trial

schemapapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This randomized controlled trial compares the long-term outcomes of 25 versus 50 sessions of psychodynamic or schema therapy for outpatients with depression and personality disorders. The study reports that while higher dosage led to faster initial improvements, depression severity and remission rates at 18 and 24 months did not significantly differ between the two dosage groups. The resource is intended for researchers and clinicians interested in treatment duration effects within this specific clinical population.

ID
9df4a3bbaf704d0a
Source org
PubMed Central
Author
Not recorded
Published
Not recorded
OA status
Not recorded
DOI
10.1017/S0033291725101025
PMID
Not recorded
PMCID
Not recorded
Citations
Not recorded

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:9df4a3bbaf704d0a,
  title = {Long-term dosage effects of psychodynamic and schema therapy in depressed patients with personality disorders: 18 and 24 months follow-up of a randomized controlled trial},
  journal = {PubMed Central},
  doi = {10.1017/S0033291725101025},
  url = {https://doi.org/10.1017/S0033291725101025}
}

RIS

TY  - JOUR
TI  - Long-term dosage effects of psychodynamic and schema therapy in depressed patients with personality disorders: 18 and 24 months follow-up of a randomized controlled trial
PB  - PubMed Central
DO  - 10.1017/S0033291725101025
UR  - https://doi.org/10.1017/S0033291725101025
ER  -

APA

Long-term dosage effects of psychodynamic and schema therapy in depressed patients with personality disorders: 18 and 24 months follow-up of a randomized controlled trial. (n.d.). PubMed Central. https://doi.org/10.1017/S0033291725101025

Related entries

More like this